FDA Inspection
Exel Inc.Exel Inc. – FDA Inspection, Nov 25, 2024
Record Details
This FDA Inspection record concerns Exel Inc., with an inspection on November 25, 2024, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · 170f6ea8-8426-45d5-a516-c2cc981d3568
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1256232
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.125(f)Procedures Written and Followed
- 21 CFR 211.170(b)Reserve samples identified, representative, stored
- 21 CFR 211.180(e)(2)Review of problem drugs
- 21 CFR 211.67(b)Written procedures fail to include
- 21 CFR 211.192Written record of investigation incomplete
- 21 CFR 211.182Written records kept in individual logs
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.